Rankings
▼
Calendar
ARCT FY 2022 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena
ARCT
Arcturus Therapeutics Holdings Inc.
$217M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$206M
+1564.8% YoY
Gross Profit
$206M
100.0% margin
Operating Income
$12M
5.9% margin
Net Income
$9M
4.5% margin
EPS (Diluted)
$0.35
Cash Flow
Operating Cash Flow
$32M
Free Cash Flow
$24M
Stock-Based Comp.
$31M
Balance Sheet
Total Assets
$450M
Total Liabilities
$180M
Stockholders' Equity
$270M
Cash & Equivalents
$392M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$206M
$12M
+1564.8%
Gross Profit
$206M
$12M
+1564.8%
Operating Income
$12M
-$203M
+106.0%
Net Income
$9M
-$204M
+104.6%
← Q4 2021
All Quarters
Q1 2022 →